Allianz Asset Management GmbH Takes Position in National Vision Holdings, Inc. $EYE

Allianz Asset Management GmbH bought a new position in National Vision Holdings, Inc. (NASDAQ:EYE) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 287,431 shares of the company’s stock, valued at approximately $8,390,000.

A number of other institutional investors have also recently bought and sold shares of EYE. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in National Vision by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,257 shares of the company’s stock worth $591,000 after purchasing an additional 1,948 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of National Vision by 6.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 235,125 shares of the company’s stock valued at $3,005,000 after purchasing an additional 13,384 shares during the last quarter. IFP Advisors Inc purchased a new stake in shares of National Vision during the 2nd quarter valued at $83,000. CWM LLC increased its holdings in shares of National Vision by 7.4% during the 2nd quarter. CWM LLC now owns 12,350 shares of the company’s stock worth $284,000 after buying an additional 856 shares during the last quarter. Finally, Bayforest Capital Ltd acquired a new stake in shares of National Vision during the 2nd quarter worth $196,000.

National Vision Price Performance

Shares of NASDAQ EYE opened at $28.70 on Tuesday. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.53 and a quick ratio of 0.32. National Vision Holdings, Inc. has a 1-year low of $10.45 and a 1-year high of $30.02. The company has a market capitalization of $2.28 billion, a price-to-earnings ratio of -956.35, a PEG ratio of 1.65 and a beta of 1.39. The business has a 50-day moving average of $27.64 and a 200-day moving average of $26.14.

Wall Street Analysts Forecast Growth

EYE has been the topic of a number of research analyst reports. Barclays lifted their target price on National Vision from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Tuesday, November 18th. Morgan Stanley lifted their price objective on National Vision from $26.00 to $30.00 and gave the company an “equal weight” rating in a research note on Thursday, January 15th. UBS Group decreased their target price on National Vision from $41.00 to $39.00 and set a “buy” rating for the company in a report on Tuesday, November 18th. Weiss Ratings reissued a “sell (d-)” rating on shares of National Vision in a research report on Thursday, January 22nd. Finally, Wall Street Zen cut shares of National Vision from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, National Vision currently has an average rating of “Moderate Buy” and a consensus target price of $29.00.

National Vision Company Profile

National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price‐conscious consumer segments.

Through its primary retail brands—including America’s Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.